The Cambridge post-mastectomy radiotherapy (C-PMRT) index: A practical tool for patient selection

Radiotherapy and Oncology

Volumn 110, Issue 3, 2014, Pages 461-466

  Mukesh, Mukesh B ^a   Duke, Simon ^a   Parashar, Deepak ^b,c   Wishart, Gordon ^d   Coles, Charlotte E ^a   Wilson, Charles ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MRC BIOSTATISTICS UNIT   (United Kingdom)

^d ANGLIA RUSKIN UNIVERSITY   (United Kingdom)

Author keywords

Breast cancer; Post mastectomy radiotherapy

Indexed keywords

ANTHRACYCLINE; TAXANE DERIVATIVE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CAMBRIDGE POSTMASTECTOMY RADIOTHERAPY INDEX; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; META ANALYSIS; OVERALL SURVIVAL; PATIENT SELECTION; POSTMASTECTOMY RADIOTHERAPY; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RISK ASSESSMENT; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME; TUMOR VOLUME; BREAST NEOPLASMS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RISK; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; RISK;

EID: 84899553468     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.09.024     Document Type: Article

References (38)

1. M. Overgaard, P.S. Hansen, and J. Overgaard et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b trial N Engl J Med 337 1997 949 955
2. M. Overgaard, M.B. Jensen, and J. Overgaard et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial Lancet 353 1999 1641 1648
3. J. Ragaz, I.A. Olivotto, and J.J. Spinelli et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial J Natl Cancer Inst 97 2005 116 126
4. P.T. Truong, I.A. Olivotto, T.J. Whelan, and M. Levine Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy CMAJ 170 2004 1263 1273
5. A. Recht, S.B. Edge, and L.J. Solin et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology J Clin Oncol 19 2001 1539 1569
6. J.R. Harris, P. Halpin-Murphy, M. McNeese, N.P. Mendenhall, M. Morrow, and N.J. Robert Consensus statement on postmastectomy radiation therapy Int J Radiat Oncol Biol Phys 44 1999 989 990
7. T. Whelan, and M. Levine More evidence that locoregional radiation therapy improves survival: what should we do? J Natl Cancer Inst 97 2005 82 84
8. I. Kunkler Re: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial J Natl Cancer Inst 97 2005 1162 1163 [author reply 63-4]
9. E. Ceilley, R. Jagsi, and S. Goldberg et al. Radiotherapy for invasive breast cancer in North America and Europe: results of a survey Int J Radiat Oncol Biol Phys 61 2005 365 373
10. R. Jagsi, R.A. Raad, and S. Goldberg et al. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation Int J Radiat Oncol Biol Phys 62 2005 1035 1039
11. R. Abi-Raad, R. Boutrus, and R. Wang et al. Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients treated with mastectomy: implications for postmastectomy radiotherapy Int J Radiat Oncol Biol Phys 81 2011 e151 e157
12. N.P. Rowell Radiotherapy to the chest wall following mastectomy for node-negative breast cancer: a systematic review Radiother Oncol 91 2009 23 32
13. A. Wallgren, M. Bonetti, and R.D. Gelber et al. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII J Clin Oncol 21 2003 1205 1213
14. A. Recht, R. Gray, and N.E. Davidson et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group J Clin Oncol 17 1999 1689 1700
15. Southwest Oncology Group (SWOG). Randomized trial of postmastectomy radiotherapy in stage II breast cancer in women with one to three positive axillary nodes, phase III (SWOG 9927). http://swog.org/visitors/ ViewProtocolDetails.asp?ProtocoIID-1807. http://www.swog.org; 6/2003 update.
16. I.H. Kunkler, P. Canney, G. van Tienhoven, and N.S. Russell Elucidating the role of chest wall irradiation in 'intermediate-risk' breast cancer: the MRC/EORTC SUPREMO trial Clin Oncol (R Coll Radiol) 20 2008 31 34
17. M. Clarke, R. Collins, and S. Darby et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 2005 2087 2106
18. M. Overgaard, H.M. Nielsen, and J. Overgaard Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials Radiother Oncol 82 2007 247 253
19. M.L. Sautter-Bihl, R. Souchon, and W. Budach et al. DEGRO practical guidelines for radiotherapy of breast cancer II. Postmastectomy radiotherapy, irradiation of regional lymphatics, and treatment of locally advanced disease Strahlenther Onkol 184 2008 347 353
20. National comprehensive cancer network clinical practice guidelines in oncology: breast cancer, Version 1, 2012. http://www.nccn.org/professionals/ physician-gls/pdf/breast.pdf.
21. P.M. Ravdin, L.A. Siminoff, and G.J. Davis et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer J Clin Oncol 19 2001 980 991
22. G.C. Wishart, E.M. Azzato, and D.C. Greenberg et al. PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer Breast Cancer Res 12 2010 R1
23. M.P. Greenbaum, E.A. Strom, and P.K. Allen et al. Low locoregional recurrence rates in patients treated after 2000 with doxorubicin based chemotherapy, modified radical mastectomy, and post-mastectomy radiation Radiother Oncol 95 2009 312 316
24. A. Katz, E.A. Strom, and T.A. Buchholz et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation J Clin Oncol 18 2000 2817 2827
25. S. Galper, A. Recht, and B. Silver et al. Factors associated with regional nodal failure in patients with early stage breast cancer with 0-3 positive axillary nodes following tangential irradiation alone Int J Radiat Oncol Biol Phys 45 1999 1157 1166
26. R.D. Tendulkar, S. Rehman, and M.E. Shukla et al. Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy Int J Radiat Oncol Biol Phys 83 2012 e577 e581
27. M. Kyndi, M. Overgaard, H.M. Nielsen, F.B. Sorensen, H. Knudsen, and J. Overgaard High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c Radiother Oncol 90 2009 74 79
28. J.A. van der Hage, H. Putter, J. Bonnema, H. Bartelink, P. Therasse, and C.J. van de Velde Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis Eur J Cancer 39 2003 2192 2199
29. M. Kyndi, F.B. Sorensen, H. Knudsen, M. Overgaard, H.M. Nielsen, and J. Overgaard Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group J Clin Oncol 26 2008 1419 1426
30. J. Selz, D. Stevens, L. Jouanneau, A. Labib, and R. Le Scodan Prognostic value of molecular subtypes, ki67 expression and impact of postmastectomy radiation therapy in breast cancer patients with negative lymph nodes after mastectomy Int J Radiat Oncol Biol Phys 84 2012 1123 1132
31. L.S. Dominici, E.A. Mittendorf, and X. Wang et al. Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy Breast Cancer Res 14 2012 R82
32. K.D. Voduc, M.C. Cheang, S. Tyldesley, K. Gelmon, T.O. Nielsen, and H. Kennecke Breast cancer subtypes and the risk of local and regional relapse J Clin Oncol 28 2010 1684 1691
33. E.P. Mamounas, G. Tang, and B. Fisher et al. Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20 J Clin Oncol 28 2010 1677 1683
34. E.H. Romond, E.A. Perez, and J. Bryant et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med 353 2005 1673 1684
35. L.P. Muren, G. Maurstad, R. Hafslund, G. Anker, and O. Dahl Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer Radiother Oncol 62 2002 173 183
36. S.C. Darby, P. McGale, C.W. Taylor, and R. Peto Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries Lancet Oncol 6 2005 557 565
37. A. Berrington de Gonzalez, R.E. Curtis, and E. Gilbert et al. Second solid cancers after radiotherapy for breast cancer in SEER cancer registries Br J Cancer 102 2010 220 226
38. G.A. Whitfield, G. Horan, M.S. Irwin, C.M. Malata, G.C. Wishart, and C.B. Wilson Incidence of severe capsular contracture following implant-based immediate breast reconstruction with or without postoperative chest wall radiotherapy using 40 Gray in 15 fractions Radiother Oncol 90 2009 141 147